Classification of α-synuclein-induced changes in the AAV α-synuclein rat model of Parkinson’s disease using electrophysiological measurements of visual processing
Abstract Biomarkers suitable for early diagnosis and monitoring disease progression are the cornerstone of developing disease-modifying treatments for neurodegenerative diseases such as Parkinson’s disease (PD). Besides motor complications, PD is also characterized by deficits in visual processing....
Guardado en:
Autores principales: | Freja Gam Østergaard, Marc M. Himmelberg, Bettina Laursen, Hartwig R. Siebner, Alex R. Wade, Kenneth Vielsted Christensen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0d30f39be362461791363a38bd12b9f6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The TCR repertoire of α-synuclein-specific T cells in Parkinson’s disease is surprisingly diverse
por: Akul Singhania, et al.
Publicado: (2021) -
α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease
por: Cecilia S. Lindestam Arlehamn, et al.
Publicado: (2020) -
ABBV-0805, a novel antibody selective for soluble aggregated α-synuclein, prolongs lifespan and prevents buildup of α-synuclein pathology in mouse models of Parkinson's disease
por: Eva Nordström, et al.
Publicado: (2021) -
α-Synuclein interacts directly but reversibly with psychosine: implications for α-synucleinopathies
por: Hazem Abdelkarim, et al.
Publicado: (2018) -
Examining the Toxicity of α-Synuclein in Neurodegenerative Disorders
por: Frank Y. Shan, et al.
Publicado: (2021)